DoD Gulf War Illness, New Investigator Award | W81XWH 19 GWIRP NIA

Opportunity Information: Apply for W81XWH 19 GWIRP NIA

The DoD Gulf War Illness Research Program (GWIRP) New Investigator Award (FY19) is a funding opportunity from the Department of Defense (USAMRAA, Department of the Army) aimed at bringing new researchers into the Gulf War Illness (GWI) field and helping them generate early, proof-of-principle results. A central goal is to let investigators who are not yet established in GWI compete in a lane separate from long-standing GWI research groups, which is intended to lower barriers for new entrants and encourage fresh approaches. The program is positioned in the Discovery or Qualification phase, meaning it is geared toward exploring promising ideas and producing evidence strong enough to justify larger follow-on studies, rather than requiring a fully mature, late-stage clinical program from the start.

The award is specifically built for principal investigators who fit one of three eligibility pathways: transitioning postdoctoral fellows, early-career investigators, or researchers who are new to GWI research. Prior GWI experience is allowed but is not required. At the same time, if the proposed PI has a limited GWI background, the solicitation strongly encourages building meaningful collaborations with investigators who do have GWI expertise or other highly relevant scientific or clinical expertise. Applicants are expected to explain, in practical terms, how those collaborators will strengthen the project, fill gaps in the PI's experience, and increase the likelihood that the research question can be answered credibly.

In terms of what can be proposed, the scope is broad across the research spectrum, from basic science through clinical research, as long as the work is clearly tied to Gulf War Illness. The emphasis is on innovative ideas and early validation, such as testing a novel hypothesis, piloting a new method or model, or producing initial data that can de-risk a future, larger study. The program also makes it clear that work that explores mechanisms outside the context of GWI is not responsive; even if the science is interesting, it needs to be framed directly around GWI and the unique features of the condition as experienced by Veterans of the 1990 to 1991 Gulf War.

A notable feature of this mechanism is that preliminary data are not required. Applicants can include preliminary findings if they have them, but the solicitation explicitly allows those data to come from outside the GWI field. In other words, someone could bring observations, methods, or early results from related illnesses or adjacent biomedical areas and adapt them to a GWI-focused research question. If an application does not include preliminary data, it is expected to rest on a strong scientific rationale, which could include well-supported theory, convincing logic based on existing literature, or credible clinical observations.

Every application must make a clear case for impact on Veterans with GWI. Even if the project is not expected to produce an immediate therapy or diagnostic, the proposal must explain how the anticipated results could lead to clinical impact over time, such as clarifying disease mechanisms that point to treatable targets, identifying biomarkers that could improve diagnosis or stratification, or laying groundwork for intervention development. The focus is explicitly on Gulf War Illness and on Gulf War Veterans affected by it, and the PI is responsible for making that connection direct and explicit rather than implied.

For FY19, the GWIRP also listed topics of special interest, signaling areas the program particularly wanted to see explored. Applicants were not limited to those topics and could propose any GWI-relevant area aligned with the program mission and overarching challenges, but the key constraint remained the same: the work must be rooted in Gulf War Illness rather than using GWI only as a distant or optional application.

Administratively, this opportunity was released under Funding Opportunity Number W81XWH-19-GWIRP-NIA. It is categorized as discretionary funding and can be awarded as either a grant or a cooperative agreement. Eligible applicants were listed as unrestricted (open to any type of entity, subject to any additional eligibility details in the full announcement). The CFDA number is 12.420. The opportunity was created on May 16, 2019, with an original closing date of October 3, 2019. The public synopsis lists an expected number of awards as 1 and shows an award ceiling of 0, which typically means applicants needed to rely on the full announcement for the actual funding limits and budget rules rather than the synopsis line item.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Gulf War Illness, New Investigator Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on May 16, 2019.
• Applicants must submit their applications by Oct 03, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 19 GWIRP NIA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: